Domainex announced an extension of its research agreement with Ark Therapeutics

Domainex announced an extension of its research agreement with Ark Therapeutics. Under the terms of the agreement Domainex will continue to provide Ark with hit-finding and lead optimization services for drug discovery against novel and exciting therapeutic targets nominated by the company.